文献速递糖尿病肥胖与代谢综合征

IMI-DIRECT研究中人血浆代谢物在糖尿病前期和2型糖尿病中的作用

Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study.
PubMed 文献 · Diabetologia · 2024-09-30

在IMI-DIRECT研究中对3000份血浆样本进行靶向和非靶向代谢组学检测,911种代谢物通过质控。分析发现支链氨基酸、脂质等代谢物与血糖谱显著相关,并可介导从基线到随访18和48个月的2型糖尿病效应;孟德尔随机化提示特定磷脂和n-3脂肪酸对2型糖尿病有潜在因果作用。

要点

  • 支链氨基酸、部分脂质和N-乳酰氨基酸代谢物与糖尿病前期及2型糖尿病显著相关。
  • 这些代谢物可介导从基线到随访18和48个月的2型糖尿病效应。
  • 遗传变异分析提示特定磷脂和n-3脂肪酸对2型糖尿病有因果作用。

核心结论

  • 已知的支链氨基酸和脂质以及新型N-乳酰氨基酸代谢物与糖尿病前期和糖尿病显著相关,并介导从基线到随访18和48个月的糖尿病效应。
  • 遗传变异因果推断显示脂质代谢和n-3脂肪酸对代谢物至2型糖尿病有因果作用,而己糖总和对2型糖尿病至代谢物有因果作用。
  • 所识别的代谢物标志物有助于根据风险进展对个体进行分层,并应能实现靶向干预。

研究设计与样本

  • 作为创新药物计划-患者分层糖尿病研究(IMI-DIRECT)联盟的一部分,采用Biocrates AbsoluteIDQ p150试剂盒和Metabolon分析平台检测3000份血浆样本。
  • 共911种代谢物(132种靶向代谢组学、779种非靶向代谢组学)通过质量控制。
  • 采用多变量线性和逻辑回归分析,以每种代谢物浓度/峰面积为解释变量、血糖状态为因变量,基本模型校正年龄、性别、BMI和研究中心,完整模型额外校正酒精、吸烟、血压、空腹HDL胆固醇和空腹甘油三酯。
  • 统计显著性全程采用Bonferroni校正。
  • 采用因果中介检验和两样本孟德尔随机化(2SMR)方法分别研究中介效应和因果效应,2SMR使用英国生物银行全基因组关联研究的汇总统计量。

主要发现

  • 靶向代谢组学中,正常血糖调节对比糖调节受损/糖尿病前期、正常血糖调节对比2型糖尿病、糖调节受损对比2型糖尿病分别观察到4种(非靶向代谢组学中为15种)、34种(99种)和50种(108种)代谢物显著不同。
  • 显著代谢物主要为支链氨基酸(BCAAs),包括一些衍生化BCAAs、脂质、外源物质和少数未知物。
  • 溶血磷脂酰胆碱a C17:0、己糖总和、来自BCAA代谢的氨基酸(包括亮氨酸、异亮氨酸、缬氨酸、N-乳酰缬氨酸、N-乳酰亮氨酸和亚胺甲基谷氨酸)和乳酸以及未知代谢物(X-24295)与HbA1c进展速率相关,并且是从基线到随访18和48个月2型糖尿病的显著中介物。
  • 2SMR发现2型糖尿病对三种代谢物(己糖、谷氨酸和己酸[脂肪酸(FA) 6:0])水平有因果效应,而特定磷脂酰胆碱(PC aa C36:2、PC aa C36:5、PC ae C36:3和PC ae C34:3)以及两种n-3脂肪酸硬脂idonate(18:4n3)和二十二碳五烯酸(22:5n3)对2型糖尿病发生有潜在因果作用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Type 2 diabetes is a chronic condition that is caused by hyperglycaemia. Our aim was to characterise the metabolomics to find their association with the glycaemic spectrum and find a causal relationship between metabolites and type 2 diabetes. METHODS: As part of the Innovative Medicines Initiative - Diabetes Research on Patient Stratification (IMI-DIRECT) consortium, 3000 plasma samples were measured with the Biocrates AbsoluteIDQ p150 Kit and Metabolon analytics. A total of 911 metabolites (132 targeted metabolomics, 779 untargeted metabolomics) passed the quality control. Multivariable linear and logistic regression analysis estimates were calculated from the concentration/peak areas of each metabolite as an explanatory variable and the glycaemic status as a dependent variable. This analysis was adjusted for age, sex, BMI, study centre in the basic model, and additionally for alcohol, smoking, BP, fasting HDL-cholesterol and fasting triacylglycerol in the full model. Statistical significance was Bonferroni corrected throughout. Beyond associations, we investigated the mediation effect and causal effects for which causal mediation test and two-sample Mendelian randomisation (2SMR) methods were used, respectively. RESULTS: In the targeted metabolomics, we observed four (15), 34 (99) and 50 (108) metabolites (number of metabolites observed in untargeted metabolomics appear in parentheses) that were significantly different when comparing normal glucose regulation vs impaired glucose regulation/prediabetes, normal glucose regulation vs type 2 diabetes, and impaired glucose regulation vs type 2 diabetes, respectively. Significant metabolites were mainly branched-chain amino acids (BCAAs), with some derivatised BCAAs, lipids, xenobiotics and a few unknowns. Metabolites such as lysophosphatidylcholine a C17:0, sum of hexoses, amino acids from BCAA metabolism (including leucine, isoleucine, valine, N-lactoylvaline, N-lactoylleucine and formiminoglutamate) and lactate, as well as an unknown metabolite (X-24295), were associated with HbA1c progression rate and were significant mediators of type 2 diabetes from baseline to 18 and 48 months of follow-up. 2SMR was used to estimate the causal effect of an exposure on an outcome using summary statistics from UK Biobank genome-wide association studies. We found that type 2 diabetes had a causal effect on the levels of three metabolites (hexose, glutamate and caproate [fatty acid (FA) 6:0]), whereas lipids such as specific phosphatidylcholines (PCs) (namely PC aa C36:2, PC aa C36:5, PC ae C36:3 and PC ae C34:3) as well as the two n-3 fatty acids stearidonate (18:4n3) and docosapentaenoate (22:5n3) potentially had a causal role in the development of type 2 diabetes. CONCLUSIONS/INTERPRETATION: Our findings identify known BCAAs and lipids, along with novel N-lactoyl-amino acid metabolites, significantly associated with prediabetes and diabetes, that mediate the effect of diabetes from baseline to follow-up (18 and 48 months). Causal inference using genetic variants shows the role of lipid metabolism and n-3 fatty acids as being causal for metabolite-to-type 2 diabetes whereas the sum of hexoses is causal for type 2 diabetes-to-metabolite. Identified metabolite markers are useful for stratifying individuals based on their risk progression and should enable targeted interventions.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Sharma S, Dong Q, Haid M, et al. Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study. Diabetologia. 2024. PMID: 39349772. doi:10.1007/s00125-024-06282-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。